Bumper haul of expensive new drugs heads to US, Europe

London

DRUG companies have brought a host of expensive new medicines to market in the United States and Europe this year, figures show, another bumper haul for an industry often accused of over-charging.

Drug prices are set to be a major issue in the run-up to the US presidential election next year, with Democratic candidate Hillary Clinton having pledged to rein in costs in a country that has the world's highest prices.